NTUS News and Press, Natus Medical Incorporated From 05/12/20

PLEASANTON, Calif., May 12, 2020 (GLOBE NEWSWIRE) -- Natus Medical Incorporated (NASDAQ:NTUS) (the “Company” or “Natus”), a leading provider of medical device solutions focused on the diagnosis and treatment of central nervous and sensory system disorders for p...

PLEASANTON, Calif., May 08, 2020 (GLOBE NEWSWIRE) -- Natus Medical Incorporated (NASDAQ: NTUS) (the “Company” or “Natus”), a leading provider of medical device solutions focused on the diagnosis and treatment of central nervous and sensory system disorders for ...

Natus Medical Incorporated (NTUS) Q1 2020 Earnings Conference Call April 30, 2020 04:30 PM ET Company Participants Jonathan Kennedy - President & Chief Executive Officer Drew Davies - Executive Vice President & Chief Financial Officer Conference Call Participants Jays...

Image source: The Motley Fool. Natus Medical   (NASDAQ: NTUS) Q1 2020 Earnings Call Apr 30, 2020 , 4:30 p.m. ET Operator Continue reading

Natus Medical (NASDAQ: NTUS ): Q1 Non-GAAP EPS of $0.04 misses by $0.18 ; GAAP EPS of $0.11 beats by $0.01 . More news on: Natus Medical Incorporated, Earnings news and commentary, Healthcare stocks news, Read more ...

PLEASANTON, Calif., April 30, 2020 (GLOBE NEWSWIRE) -- Natus Medical Incorporated (NASDAQ:NTUS) (the “Company” or “Natus”), a leading provider of medical device solutions focused on the diagnosis and treatment of central nervous and sensory system disorders fo...

New York City, NY: April 07, 2020 – Recent Research and Future Market Potential of Electroencephalogram Meter Market in Global Industry: 2020 Research and New Innovations in Medical Devices Sector. The prime objective of the report is to offer updates and information related to future ...

New York City, NY: April 07, 2020 – Recent Research and Future Market Potential of Electromyograph Market in Global Industry: 2020 Research and New Innovations in Medical Devices Sector. The prime objective of the report is to offer updates and information related to future opportuniti...

On a preliminary basis , Natus Medical (NASDAQ: NTUS ) sees Q1 revenue of $109M - 110M versus guidance of $113M - 117M and consensus of $115M. More news on: Natus Medical Incorporated, Healthcare stocks news, Earnings news and commentary, Stocks on the move, Read more ...

PLEASANTON, Calif., April 06, 2020 (GLOBE NEWSWIRE) -- Natus Medical Incorporated (NASDAQ:NTUS) (the “Company” or “Natus”), a leading provider of medical device solutions focused on the diagnosis and treatment of central nervous and sensory system disorders for...